Open access
95
Views
18
CrossRef citations to date
0
Altmetric
Original Research
Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis
John R Hurst1 UCL Respiratory, University College London, London, UKCorrespondence[email protected]
, Maria Dilleen2 Statistics, Global Product Development, Pfizer, Tadworth, UK
, Kevin Morris3 Medical Affairs, Pfizer, Tadworth, UK
, Siân Hills3 Medical Affairs, Pfizer, Tadworth, UK
, Birol Emir4 Biostatistics, Global Product Development, Pfizer, New York, NY, USA
& Rupert Jones5 Clinical Trials & Health Research, Institute of Translational and Stratified Medicine, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK
Pages 781-792
|
Published online: 05 Mar 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.